Suppr超能文献

串联DNA重复序列的DNA甲基化变化在癌症中与散布重复序列不同。

Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer.

作者信息

Choi Si Ho, Worswick Scott, Byun Hyang-Min, Shear Talia, Soussa John C, Wolff Erika M, Douer Dan, Garcia-Manero Guillermo, Liang Gangning, Yang Allen S

机构信息

Jane Anne Nohl Division of Hematology, Center for Blood Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Int J Cancer. 2009 Aug 1;125(3):723-9. doi: 10.1002/ijc.24384.

Abstract

Hypomethylation of DNA repetitive elements is a common finding in cancer, but very little is known about the DNA methylation changes of different types of DNA repetitive elements, such as interspersed repeats (LINE1 and Alu Yb8) and tandem repeats (Sat-alpha, NBL-2 and D4Z4). We used bisulfite-PCR Pyrosequencing to quantitatively measure the DNA methylation of five different DNA repetitive elements in normal tissue and cancer. In all we studied 10 different tissues from four individuals undergoing autopsy, 34 paired normal and tumor tissues from patients with bladder cancer, 58 patients with chronic myelogenous leukemia and 23 patients with acute promyelocytic leukemia. We found that the DNA methylation of interspersed repeats (LINE1 and Alu Yb8) was very consistent from person to person and tissue to tissue while tandem DNA repeats appeared more variable in normal tissues. In bladder cancer we found clear hypomethylation of LINE1, Alu Yb8, Sat-alpha and NBL-2. Conversely, we found an increase in the DNA methylation levels of D4Z4 from normal to cancer. In contrast leukemia showed no significant changes in the DNA methylation of LINE1 and Alu Yb8, but DNA methylation increases in NBL-2 and D4Z4 tandem repeats. Our findings show that the changes in DNA methylation levels of individual DNA repetitive elements are unique for each repetitive element, which may reflect distinct epigenetic factors and may have important implications in the use of DNA methylation of repetitive elements as global DNA methylation biomarkers.

摘要

DNA重复元件的低甲基化是癌症中的常见现象,但对于不同类型的DNA重复元件,如散布重复序列(LINE1和Alu Yb8)和串联重复序列(Sat-alpha、NBL-2和D4Z4)的DNA甲基化变化,人们了解甚少。我们使用亚硫酸氢盐PCR焦磷酸测序法定量测量正常组织和癌症中五种不同DNA重复元件的DNA甲基化。我们总共研究了来自四名接受尸检的个体的10种不同组织、34对膀胱癌患者的正常组织和肿瘤组织、58例慢性粒细胞白血病患者以及23例急性早幼粒细胞白血病患者。我们发现,散布重复序列(LINE1和Alu Yb8)的DNA甲基化在人与人、组织与组织之间非常一致,而串联DNA重复序列在正常组织中表现出更大的变异性。在膀胱癌中,我们发现LINE1、Alu Yb8、Sat-alpha和NBL-2明显低甲基化。相反,我们发现从正常组织到癌组织,D4Z4的DNA甲基化水平增加。相比之下,白血病中LINE1和Alu Yb8的DNA甲基化没有显著变化,但NBL-2和D4Z4串联重复序列的DNA甲基化增加。我们的研究结果表明,单个DNA重复元件的DNA甲基化水平变化对于每个重复元件都是独特的,这可能反映了不同的表观遗传因素,并且可能对将重复元件的DNA甲基化用作整体DNA甲基化生物标志物具有重要意义。

相似文献

2
Alu and Satα hypomethylation in Helicobacter pylori-infected gastric mucosae.
Int J Cancer. 2011 Jan 1;128(1):33-9. doi: 10.1002/ijc.25534.
3
Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
Carcinogenesis. 2009 Aug;30(8):1330-5. doi: 10.1093/carcin/bgp149. Epub 2009 Jun 16.
4
LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients.
Gynecol Oncol. 2014 Feb;132(2):462-7. doi: 10.1016/j.ygyno.2013.12.024. Epub 2013 Dec 25.
5
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Leuk Res. 2008 Mar;32(3):487-90. doi: 10.1016/j.leukres.2007.07.021. Epub 2007 Sep 4.
7
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.
Diagn Pathol. 2018 Dec 22;13(1):98. doi: 10.1186/s13000-018-0777-x.
8
Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization.
Cancer Causes Control. 2012 Jun;23(6):865-73. doi: 10.1007/s10552-012-9955-4. Epub 2012 Apr 19.
9
Aberrant DNA methylation patterns of spermatozoa in men with unexplained infertility.
Hum Reprod. 2015 May;30(5):1014-28. doi: 10.1093/humrep/dev053. Epub 2015 Mar 9.

引用本文的文献

1
GSK-3484862, a DNMT1 degrader, promotes expression in lung cancer cells.
NAR Cancer. 2025 May 27;7(2):zcaf018. doi: 10.1093/narcan/zcaf018. eCollection 2025 Jun.
2
Dysregulation of Locus-Specific Repetitive Elements in TCGA Pan-Cancers.
Genes (Basel). 2025 Apr 29;16(5):528. doi: 10.3390/genes16050528.
3
Fundamentals of DNA methylation in development.
Pediatr Res. 2024 Dec 10. doi: 10.1038/s41390-024-03674-7.
4
The formation and propagation of human Robertsonian chromosomes.
bioRxiv. 2024 Sep 26:2024.09.24.614821. doi: 10.1101/2024.09.24.614821.
5
Comprehensive identification of onco-exaptation events in bladder cancer cell lines revealed L1PA2-SYT1 as a prognosis-relevant event.
iScience. 2023 Nov 17;26(12):108482. doi: 10.1016/j.isci.2023.108482. eCollection 2023 Dec 15.
6
The influence of early environment and micronutrient availability on developmental epigenetic programming: lessons from the placenta.
Front Cell Dev Biol. 2023 Jul 6;11:1212199. doi: 10.3389/fcell.2023.1212199. eCollection 2023.
7
Gene body methylation in cancer: molecular mechanisms and clinical applications.
Clin Epigenetics. 2022 Nov 28;14(1):154. doi: 10.1186/s13148-022-01382-9.

本文引用的文献

1
Cyclical DNA methylation of a transcriptionally active promoter.
Nature. 2008 Mar 6;452(7183):45-50. doi: 10.1038/nature06544.
2
Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers.
Nucleic Acids Res. 2008 Apr;36(7):2196-207. doi: 10.1093/nar/gkn055. Epub 2008 Feb 16.
3
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Leuk Res. 2008 Mar;32(3):487-90. doi: 10.1016/j.leukres.2007.07.021. Epub 2007 Sep 4.
4
Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition.
Br J Haematol. 2007 Sep;138(5):616-23. doi: 10.1111/j.1365-2141.2007.06707.x.
5
Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice.
Oncogene. 2008 Jan 10;27(3):404-8. doi: 10.1038/sj.onc.1210631. Epub 2007 Jul 9.
6
Environmental epigenomics and disease susceptibility.
Nat Rev Genet. 2007 Apr;8(4):253-62. doi: 10.1038/nrg2045.
7
Changes in DNA methylation patterns in subjects exposed to low-dose benzene.
Cancer Res. 2007 Feb 1;67(3):876-80. doi: 10.1158/0008-5472.CAN-06-2995.
9
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.
Blood. 2006 Nov 15;108(10):3271-9. doi: 10.1182/blood-2006-03-009142. Epub 2006 Aug 1.
10
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia.
Cancer Res. 2006 May 15;66(10):5495-503. doi: 10.1158/0008-5472.CAN-05-2385.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验